KRAS and TP53 Mutations in Colorectal Carcinoma

Por Al-Kuraya, Khawla S.
Publicado em 2009

Tissue microarrays for high-throughput molecular pathology

Por Al Kuraya, Khawla, Simon, Ronald, Sauter, Guido
Publicado no Ann Saudi Med (2004)

MMP7 Polymorphisms - A New Tool in Molecular Pathology to Understand Esophageal Cancer

Por Bavi, Prashant P., Bu, Rong, Uddin, Shahab, Al-Kuraya, Khawla S.
Publicado em 2011

Response to Yehia et al.

Por Siraj, Abdul K., Masoodi, Tariq, Alkuraya, Fowzan S., Al-Kuraya, Khawla S.
Publicado no Am J Hum Genet (2017)

PIK3CA alterations in Middle Eastern ovarian cancers

Por Abubaker, Jehad, Bavi, Prashant, Al-Haqawi, Wael, Jehan, Zeenath, Munkarah, Adnan, Uddin, Shahab, Al-Kuraya, Khawla S
Publicado em 2009

Overexpression of leptin receptor predicts an unfavorable outcome in Middle Eastern ovarian cancer

Por Uddin, Shahab, Bu, Rong, Ahmed, Maqbool, Abubaker, Jehad, Al-Dayel, Fouad, Bavi, Prashant, Al-Kuraya, Khawla S
Publicado em 2009

Role of leptin and its receptors in the pathogenesis of thyroid cancer

Por Uddin, Shahab, Hussain, Azhar R, Siraj, Abdul K, Khan, Omar S, Bavi, Prashant P, Al-Kuraya, Khawla S
Publicado em 2011

Phosphorylated IκBα Predicts Poor Prognosis in Activated B-Cell Lymphoma and Its Inhibition with Thymoquinone Induces Apoptosis via ROS Release

Por Hussain, Azhar R., Uddin, Shahab, Ahmed, Maqbool, Al-Dayel, Fouad, Bavi, Prashant P., Al-Kuraya, Khawla S.
Publicado em 2013

SUN-132 KLF5 Is a Poor Prognostic Marker and Therapeutic Target for Middle Eastern Papillary Thyroid Carcinoma

Por Al-Kuraya, Khawla S, Siraj, Abdul K, Poyil, Pratheeshkumar, Padmaja, Divya, Parvathareddy, Sandeep Kumar, Al-Dayel, Fouad
Publicado no J Endocr Soc (2020)

Resveratrol Suppresses Constitutive Activation of AKT via Generation of ROS and Induces Apoptosis in Diffuse Large B Cell Lymphoma Cell Lines

Por Hussain, Azhar R., Uddin, Shahab, Bu, Rong, Khan, Omar S., Ahmed, Saeeda O., Ahmed, Maqbool, Al-Kuraya, Khawla S.
Publicado em 2011

Overexpression of FoxM1 offers a promising therapeutic target in diffuse large B-cell lymphoma

Por Uddin, Shahab, Hussain, Azhar R, Ahmed, Maqbool, Siddiqui, Khawar, Al-Dayel, Fouad, Bavi, Prashant, Al-Kuraya, Khawla S.
Publicado em 2012

Overexpression of Fatty Acid Synthase in Middle Eastern Epithelial Ovarian Carcinoma Activates AKT and Its Inhibition Potentiates Cisplatin-Induced Apoptosis

Por Uddin, Shahab, Jehan, Zeenath, Ahmed, Maqbool, Alyan, Aisha, Al-Dayel, Fouad, Hussain, Azhar, Bavi, Prashant, Al-Kuraya, Khawla S
Publicado em 2011

Overexpression of PARP is an independent prognostic marker for poor survival in Middle Eastern breast cancer and its inhibition can be enhanced with embelin co-treatment

Por Siraj, Abdul Khalid, Pratheeshkumar, Poyil, Parvathareddy, Sandeep Kumar, Divya, Sasidharan Padmaja, Al-Dayel, Fouad, Tulbah, Asma, Ajarim, Dahish, Al-Kuraya, Khawla S.
Publicado no Oncotarget (2018)

Cross-Talk between NFkB and the PI3-Kinase/AKT Pathway Can Be Targeted in Primary Effusion Lymphoma (PEL) Cell Lines for Efficient Apoptosis

Por Hussain, Azhar R., Ahmed, Saeeda O., Ahmed, Maqbool, Khan, Omar S., Al AbdulMohsen, Sally, Platanias, Leonidas C., Al-Kuraya, Khawla S., Uddin, Shahab
Publicado em 2012

Dual Targeting of mTOR Activity with Torin2 Potentiates Anticancer Effects of Cisplatin in Epithelial Ovarian Cancer

Por Hussain, Azhar R, Al-Romaizan, Maha, Ahmed, Maqbool, Thangavel, Saravanan, Al-Dayel, Fouad, Beg, Shaham, Uddin, Shahab, Siraj, Abdul K, Al-Kuraya, Khawla S
Publicado no Mol Med (2015)

Genomic Profiling of Thyroid Cancer Reveals a Role for Thyroglobulin in Metastasis

Por Siraj, Abdul K., Masoodi, Tariq, Bu, Rong, Beg, Shaham, Al-Sobhi, Saif S., Al-Dayel, Fouad, Al-Dawish, Mohammed, Alkuraya, Fowzan S., Al-Kuraya, Khawla S.
Publicado no Am J Hum Genet (2016)

ALK alteration is a frequent event in aggressive breast cancers

Por Siraj, Abdul K., Beg, Shaham, Jehan, Zeenath, Prabhakaran, Sarita, Ahmed, Maqbool, R.Hussain, Azhar, Al-Dayel, Fouad, Tulbah, Asma, Ajarim, Dahish, Al-Kuraya, Khawla S.
Publicado no Breast Cancer Res (2015)

Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells

Por Ahmed, Maqbool, Hussain, Azhar R, Siraj, Abdul K., Uddin, Shahab, Al-Sanea, Nasser, Al-Dayel, Fouad, Al-Assiri, Mohammed, Beg, Shaham, Al-Kuraya, Khawla S.
Publicado no Mol Cancer (2015)

Identification of novel BRCA founder mutations in Middle Eastern breast cancer patients using capture and Sanger sequencing analysis

Por Bu, Rong, Siraj, Abdul K., Al‐Obaisi, Khadija A.S., Beg, Shaham, Al Hazmi, Mohsen, Ajarim, Dahish, Tulbah, Asma, Al‐Dayel, Fouad, Al‐Kuraya, Khawla S.
Publicado no Int J Cancer (2016)

FoxM1 is an independent poor prognostic marker and therapeutic target for advanced Middle Eastern breast cancer

Por Siraj, Abdul Khalid, Pratheeshkumar, Poyil, Parvathareddy, Sandeep Kumar, Qadri, Zeeshan, Thangavel, Saravanan, Ahmed, Saeeda, Al-Dayel, Fouad, Tulbah, Asma, Ajarim, Dahish, Al-Kuraya, Khawla S.
Publicado no Oncotarget (2018)